Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TherapeuticsMD Inc (NYSE American:TXMD)

6.32
Delayed Data
As of Sep 19
 -0.33 / -4.96%
Today’s Change
3.50
Today|||52-Week Range
8.30
+9.53%
Year-to-Date

Today’s Trading

Previous close6.65
Today’s open6.76
Day’s range6.32 - 6.80
Volume1,596,904
Average volume (3 months)2,384,132
Market cap$1.4B
Dividend yield--
Data as of 8:00pm ET, 09/19/2017

Growth & Valuation

Earnings growth (last year)+6.12%
Earnings growth (this year)--
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)-3.90%
P/E ratioNM
Price/Sales58.45
Price/Book10.26

Competitors

 Today’s
change
Today’s
% change
AKCAAkcea Therapeutics I...+0.68+2.83%
ESPREsperion Therapeutic...-0.94-1.86%
BHVNBiohaven Pharmaceuti...+0.33+0.88%
FWPForward Pharma A/S-0.26-4.41%
Data as of 09/19/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$19.4M
Annual profit (last year)-$89.9M
Net profit margin-464.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Robert G. Finizio
President &
Director
John C. K. Milligan
Corporate headquarters
Boca Raton, Florida

Forecasts